The Non Small Cell Lung Cancer Disease and Therapy Review provides an overview of the disease and related conditions.
Online PR News – 15-January-2010 – – The Non Small Cell Lung Cancer Disease and Therapy Review provides an overview of the disease and related conditions, with incidence, prevalence, and mortality numbers for major countries worldwide, information on diagnosis, and an overview of treatment. General information on the lung cancer market, as well as sales of leading drugs and therapies are provided.
Disease and Therapy Reviews were developed to provide a basic understanding of the key facts about a disease and market in a quick, easy-to-read format. These reports are prepared by the senior market research team of Timely Data Resources. Each Disease and Therapy Review provides a concise analysis of the most important information about a particular disease, its treatment, and the market opportunities. Reports begin with an overview of the condition, and also contain tables that summarize the available worldwide incidence and prevalence data for the condition, a review of current diagnosis strategies and treatment options, general information about the market size, and information about important market trends. The data contained in these reports comes from key industry secondary data sources, such as the Timely Data Resources Incidence and Prevalence Database, and Lange's Current Medical Diagnosis and Treatment. This information is supplemented by reviews of analyst reports, company reports, and medical websites. Sources and references are provided.
Table Of Contents :
II. Incidence and Prevalence
INCIDENCE (NEW CASES) OF LUNG CANCER
PREVALENCE (TOTAL CASES) OF LUNG CANCER
MORTALITY OF LUNG CANCER
V. Market Size
To know more about this report & to buy a copy please visit :